220 related articles for article (PubMed ID: 38303531)
1. Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.
Singh D
Endocr Metab Immune Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38303531
[TBL] [Abstract][Full Text] [Related]
2. Future of nanotherapeutics: Targeting the cellular sub-organelles.
Ma X; Gong N; Zhong L; Sun J; Liang XJ
Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
[TBL] [Abstract][Full Text] [Related]
3. Organelle targeting: third level of drug targeting.
Sakhrani NM; Padh H
Drug Des Devel Ther; 2013; 7():585-99. PubMed ID: 23898223
[TBL] [Abstract][Full Text] [Related]
4. Intracellular delivery of nanocarriers and targeting to subcellular organelles.
Jhaveri A; Torchilin V
Expert Opin Drug Deliv; 2016; 13(1):49-70. PubMed ID: 26358656
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics.
Prajapati RN; Bhushan B; Singh K; Chopra H; Kumar S; Agrawal M; Pathak D; Chanchal DK; Laxmikant
Curr Pharm Biotechnol; 2024 Jan; ():. PubMed ID: 38288793
[TBL] [Abstract][Full Text] [Related]
6. An update on cell-penetrating peptides with intracellular organelle targeting.
Cerrato CP; Langel Ü
Expert Opin Drug Deliv; 2022 Feb; 19(2):133-146. PubMed ID: 35086398
[TBL] [Abstract][Full Text] [Related]
7. Emerging insights into mitochondria-specific targeting and drug delivering strategies: Recent milestones and therapeutic implications.
Dhanasekaran S; Venugopal D; Al-Dayan N; Ravinayagam V; Mohammed AA
Saudi J Biol Sci; 2020 Dec; 27(12):3581-3592. PubMed ID: 33304169
[TBL] [Abstract][Full Text] [Related]
8. Nanopreparations for organelle-specific delivery in cancer.
Biswas S; Torchilin VP
Adv Drug Deliv Rev; 2014 Feb; 66():26-41. PubMed ID: 24270008
[TBL] [Abstract][Full Text] [Related]
9. Limited Efficiency of Drug Delivery to Specific Intracellular Organelles Using Subcellularly "Targeted" Drug Delivery Systems.
Maity AR; Stepensky D
Mol Pharm; 2016 Jan; 13(1):1-7. PubMed ID: 26587994
[TBL] [Abstract][Full Text] [Related]
10. Smart Design of Nanomaterials for Mitochondria-Targeted Nanotherapeutics.
Liew SS; Qin X; Zhou J; Li L; Huang W; Yao SQ
Angew Chem Int Ed Engl; 2021 Feb; 60(5):2232-2256. PubMed ID: 32128948
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
Majumder J; Minko T
Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
[TBL] [Abstract][Full Text] [Related]
13. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
[TBL] [Abstract][Full Text] [Related]
14. Subcellular delivery of lipid nanoparticles to endoplasmic reticulum and mitochondria.
Shi Y; Luo Z; You J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1803. PubMed ID: 35441489
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches.
Khan T; Waseem R; Zehra Z; Aiman A; Bhardwaj P; Ansari J; Hassan MI; Islam A
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559149
[TBL] [Abstract][Full Text] [Related]
16. Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer.
Milane LS; Dolare S; Ren G; Amiji M
J Control Release; 2023 Nov; 363():435-451. PubMed ID: 37717658
[TBL] [Abstract][Full Text] [Related]
17. Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology.
Yang J; Griffin A; Qiang Z; Ren J
Signal Transduct Target Ther; 2022 Nov; 7(1):379. PubMed ID: 36402753
[TBL] [Abstract][Full Text] [Related]
18. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
20. [Advances in the study of organelles targeting nanocarriers].
Sun XY; Wei LL; Chen HL; Liang WQ
Yao Xue Xue Bao; 2009 Aug; 44(8):838-44. PubMed ID: 20055149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
